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Abstract
Background: HTLV-1 utilizes CD4 T cells as the main host cell and maintains the proviral load via clonal
proliferation of infected CD4+ T cells. Infection of CD4+ T cells by HTLV-1 is therefore thought to play a pivotal role
in HTLV-1-related pathogenicity, including leukemia/lymphoma of CD4+ T cells and chronic inflammatory diseases.
Recently, it has been reported that a proportion of HTLV-1 infected CD4+ T cells express FoxP3, a master molecule
of regulatory T cells. However, crucial questions remain unanswered on the relationship between HTLV-1 infection
and FoxP3 expression.
Results: To investigate the effect of HTLV-1 infection on CD4+ T-cell subsets, we used flow cytometry to analyze
the T-cell phenotype and HTLV-1 infection in peripheral mononuclear cells (PBMCs) of four groups of subjects,
including 23 HTLV-1-infected asymptomatic carriers (AC), 10 patients with HTLV-1 associated myelopathy/tropical
spastic paraparesis (HAM/TSP), 10 patients with adult T-cell leukemia (ATL), and 10 healthy donors. The frequency of
FoxP3+ cells in CD4+ T cells in AC with high proviral load and patients with HAM/TSP or ATL was higher than that
in uninfected individuals. The proviral load was positively correlated with the percentage of CD4+ T cells that were
FoxP3+. The CD4+FoxP3+ T cells, themselves, were frequently infected with HTLV-1. We conclude that FoxP3+ T-
cells are disproportionately infected with HTLV-1 during chronic infection. We next focused on PBMCs of HAM/TSP
patients. The expression levels of the Treg associated molecules CTLA-4 and GITR were decreased in CD4
+FoxP3+ T cells.
Further we characterized FoxP3+CD4+ T-cell subsets by staining CD45RA and FoxP3, which revealed an increase in
CD45RA−FoxP3low non-suppressive T-cells. These findings can reconcile the inflammatory phenotype of HAM/TSP with
the observed increase in frequency of FoxP3+ cells. Finally, we analyzed ATL cells and observed not only a high frequency
of FoxP3 expression but also wide variation in FoxP3 expression level among individual cases.
Conclusions: HTLV-1 infection induces an abnormal frequency and phenotype of FoxP3+CD4+ T cells.
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Background
Human T-cell leukemia virus type 1 (HTLV-1) is a
delta type retrovirus, which causes leukemia of
HTLV-1-infected CD4+ T cells, known as adult T-cell
leukemia (ATL) [1-4], in 2 to 5 % of infected indivi-
duals. HTLV-1 is also associated with chronic inflam-
matory diseases [5,6], including HTLV-1 associated
myelopathy/tropical spastic paraparesis (HAM/TSP),
uveitis, alveolitis [7], and dermatitis [8]. It has been
estimated that 20 million people are infected with
HTLV-1 in the world. HTLV-1 has a characteristic
proliferative strategy; HTLV-1 increases its copy num-
ber not via vigorous production of cell-free viral par-
ticle but mainly via proliferation of infected host
cells, which contain the integrated HTLV-1 provirus
in the host genome [9,10]. Given the fact that HTLV-
1 utilizes CD4+ T cells as the major host cell popula-
tion, the pathogenesis by this virus may be due to ab-
normalities of CD4+ T cells in HTLV-1-infected
individuals. However the precise characteristics of the
putative CD4+ T-cell abnormality still remain to be
elucidated.
In addition to viral structural proteins, such as Gag,
Pol, and Env, HTLV-1 encodes several regulatory and
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accessory proteins, including Tax, Rex, p30, p12, and
HTLV-1 bZIP factor (HBZ), which regulate viral gene
expression or proliferation of infected host cells [4].
After the HTLV-1 provirus is integrated into the host
genome, the virus expresses these regulatory and
accessory proteins to induce host cell proliferation or
viral latency, resulting in persistent infection in vivo. Tax
is known to influence various host cell-signaling path-
ways, for example activation of NF-κB, and to contribute
to proliferation and survival of infected cells [11,12]. An-
other viral gene, the HBZ, which is encoded in the
minus strand of HTLV-1 [13] and expressed constitu-
tively in the infected host cells [14,15], also contributes
to proliferation of the infected cells [14,16], dysregula-
tion of differentiation and function of CD4+ T cells [17],
and the pathogenesis of diseases such as T-cell lymph-
oma and chronic inflammatory diseases [17,18]. On the
other hand, viral protein expression induces the host im-
mune response to eliminate the virus, which includes
both antibody and cytotoxic T lymphocytes (CTL)
against the viral antigens [19-21]. It has been reported
that the CTL response against this virus determines
HTLV-1 proviral load; yet, the host immune system can-
not eliminate the HTLV-1 completely, which allows
HTLV-1 to establish persistent infection in almost all
infected individuals.
Recent studies have clarified the presence of various
CD4+ T-cell subsets. CD4+ T cells can be divided into
two major categories, effector T cells and regulatory T
cells. Effector T cells induce the activation of immune
responses by secreting pro-inflammatory cytokines
whereas regulatory T cells, which express the transcrip-
tion factor FoxP3 [22-24], suppress the immune re-
sponse by both cell-contact dependent and independent
mechanisms [25]. As an example of cell contact
dependent suppression, expression of the immune sup-
pressive molecule CTLA-4 on the cell surface inhibits
the activation of surrounding neighboring T cells [26]. In
addition, a recent report demonstrated that human
FoxP3+CD4+ T cells were composed of three phenotyp-
ically and functionally different subsets according to the
degree of FoxP3 expression and CD45RA expression,
namely CD45RA+FoxP3low resting Treg cells (rTreg cells),
CD45RA−FoxP3high activated Treg cells (aTreg cells), or
CD45RA−FoxP3low non-suppressive T cells (FoxP3low
non-Treg cells) [27]. Both rTreg cells and aTreg cells have
suppressive function, but FoxP3low non-Treg cells are
not suppressive.
Previous studies have reported that the HTLV-1 pro-
virus is enriched in effector/memory T cells [28,29], and
the phenotype of ATL cells shares certain characteristics
with regulatory T cells based on the finding of FoxP3 ex-
pression [30,31]. However there are few studies that sys-
tematically and specifically investigate which recently
described CD4+ T-cell subset is infected by HTLV-1 in
asymptomatic carriers (AC), HAM/TSP patients, and
ATL patients. To elucidate this point, we analyzed per-
ipheral mononuclear cells (PBMCs) from naturally
HTLV-1-infected individuals, including AC, HAM/TSP,
and ATL patients, by using multicolor flow cytometric
analysis combined with the detection of the viral antigen
Tax to identify the presence of HTLV-1 [32]. We found
the specific CD4+FoxP3+ T-cell subset is frequently
infected with HTLV-1, which may allow the virus
to achieve persistent infection in vivo, and should also
contribute to the pathogenesis of the virus-associated
diseases.
Results
The frequency of FoxP3+ cells is positively correlated with
HTLV-1 proviral load
Previous studies reported that the HTLV-1 provirus was
frequently detected in effector/memory CD4+ T cells
[28], but at that time the analysis did not distinguish be-
tween effector/memory CD4+ T cell and regulatory T
cells (Treg cells). Also further subsets of CD4
+ T cells
have been identified recently, such as the division of
FoxP3+CD4+ T cells into three distinct subsets [27]. In
order to uncover the impact of HTLV-1 infection on the
CD4+ T-cell subset, it is necessary to re-evaluate the
CD4+ subsets in HTLV-1-infected individuals. We ana-
lyzed 23 ACs, 10 HAM/TSP patients, 10 ATL patients,
and 10 healthy donors in this study as shown in Table 1.
Almost all ATL cells express CD4, and indeed the per-
centage of CD4+ T-cells in ATL patients was signifi-
cantly higher than that of uninfected healthy donors
(p= 0.0051, Figure 1A). There were no significant differ-
ences in the percentage of CD4+ T cells between HD,
AC, and HAM/TSP individuals (p= 0.2153 and 0.4597,
respectively, Figure 1A). To characterize the CD4+ T-cell
subset in more detail, we stained PBMCs with anti-CD4,
anti-CD45RA, and anti-FoxP3 antibodies. In this analysis
we divided CD4+ T cells into three distinct subsets,
which include two FoxP3− populations (CD45RA+ naïve
T cells and CD45RA− effector/memory T cells) and a
FoxP3+ population. As shown in Figure 1B, the percent-
age of naïve CD4+ T cells was decreased in ATL patients
(p= 0.0097), but did not differ significantly between HD,
AC and HAM/TSP (p= 0.8381 and 0.2567, respectively).
The percentages of effector/memory CD4+ T cells were
not significantly different among the four studied subject
groups (Figure 1C). However, frequencies of FoxP3+ cells
in HTLV-1 infected individuals (AChigh, ATL, HAM/
TSP) were remarkably higher than those of HD
(p= 0.0054, 0.0002 and 0.0002, respectively, Figure 1D).
The frequencies of FoxP3+ cells in AC were significantly
correlated with HTLV-1 proviral load (PVL) (r = 0.60,
p= 0.0051, Figure 1E). Additionally, the absolute number
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of each T-cell subset showed the same tendency as well
as the frequency (Additional file 1: Figure S1). These
results collectively suggested that HTLV-1 infection
increased the frequency of FoxP3+CD4+ T cells.
Tax expression after ex vivo culture is well correlated with
proviral load
It has been reported that Tax expression increases spon-
taneously during ex vivo cultivation [32], which is useful
to detect HTLV-1 infected cells at single cell level. We,
therefore, used the same method to detect HTLV-1
infected cells by flow cytometry (Figure 2A), in which we
can detect both Tax and various markers of CD4+ T-cell
subsets at the same time. We first evaluated the detec-
tion system by using a series of samples collected at dif-
ferent time points after ex vivo cultivation. We found
that a small number of Tax-expressing cells could be
detected after ex vivo cultivation for 6 hours; significant
expression could be observed after 12 hours cultivation;
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Figure 1 CD4+T-cell subset in HTLV-1 infected individuals. (A) Percentages of CD4+ T cells in 4 distinct subjects. Data shown are gated on
lymphocyte fraction based on the dot plot pattern of SSC and FSC. (B and C) Proportion of FoxP3−CD45RA+ naïve CD4+ T cells (B) or FoxP3
−CD45RA− effector/memory CD4+ T cells (C). (D) Percentages of FoxP3+ cells in CD4+ T cells. (E) Frequency of FoxP3+CD4+ cells in ACs or HAM/
TSP patients showed significant correlation with HTLV-1 proviral load by Spearman’s rank correlation (P= 0.0051 or P= 0.0268, r = 0.60 or
r = 0.7012, respectively).
Table 1 Characteristics of participants
Characteristics HD AC ATL HAM/TSP
Participant number 10 23 10 10
Age, median years (IQR) 54 (49–62) 59 (50–70) 65 (61–76) 60 (54–62)
Male sex, no (%) 3 (30) 6 (26) 5 (50) 3 (30)
WBC (IQR)/μL 4,930 (1,437) 5,157 (1,100) 17,030 (12,975) 5,900 (1,500)
Lymphocyte (IQR)/μL 1,717 (503) 1,697 (601) 8,443 (10,764) 1,739 (560)
PVL median (IQR) - 1.8 (0.5–5.0) 59.6 (18.3–67.1) 9.6 (5.6–12.0)
NOTE. HD healthy donor; AC asymptomatic HTLV-1 carrier; ATL adult T-cell leukemia; HAM/TSP HTLV-1 associated myelopathy/tropic spastic paraparesis; IQR
interquartile range; PVL proviral load. ATL patients consist of 2 acute, 4 smoldering and 4 chronic types of ATL cases.
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(Figure 2B). In order to confirm the efficiency of this
system, we analyzed the correlation between HTLV-1
proviral load and the percentage of Tax expression in
this system.
Consistent with previous reports that Tax expression
is frequently silenced in ATL cells, Tax expression after
ex vivo cultivation of ATL cells was not correlated with
the proviral load (Figure 2C). The percentage of Tax
positive cells tended to be lower than the proviral load
even after ex vivo culture in AC and HAM/TSP patients,
but we found that Tax positivity showed a significant
correlation with the proviral load both in AC and HAM/
TSP (r = 0.91 or 0.61, p= 0.00002 or 0.0334, respectively,
Figure 2D and E). In order to investigate whether T-cell
subset markers, including FoxP3 and CD45RA, are influ-
enced by ex vivo cultivation, we analyzed their expres-
sion both before and after cultivation. The results
showed that the frequency of FoxP3 or CD45RA was
not significantly changed during ex vivo culture (Add-
itional file2: Figure S2). These findings collectively
indicate the usefulness of this Tax detection system for
this study.
The frequency of HTLV-1 infection in each CD4+ T-cell
subset
We next investigated which T-cell subset is frequently
infected with HTLV-1. We cultivated PBMCs isolated
from HTLV-1 infected individuals ex vivo for 12–18 hours
and stained with antibodies to Tax and various T-cell sub-
set markers such as CD4, CD8, and FoxP3. Consistent
with the previous reports, the frequency of Tax positivity
in CD4+ T cells was much higher than that in CD8+ T cells
(p< 0.0001, Figure 3A). Among CD4+ T cells, the FoxP3
positive cell population contained a significantly higher
ratio of Tax positive cells than that in FoxP3 negative
cells (p< 0.0001, Figure 3B). In line with the finding in
Figure 1E, the frequencies of FoxP3+ cells were signifi-
cantly correlated with Tax positivity in CD4+ T cells.
(r = 0.48, p= 0.0257, Figure 3C). These results indicated
PBMC isolation 
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Figure 2 Characterization of Tax expression after ex vivo cultivation. (A) A flowchart of the experiment to detect Tax by flow cytometry. (B)
The percentages of Tax expression in CD4+ T cells after ex vivo culture are shown from 3 distinct ACs. (C–E) Correlation between Tax positivity in
CD4+ T cells and PVL in ATL patients (C), ACs (D) or HAM/TSP (E).
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that the increased FoxP3+ cells in HTLV-1-infected indivi-
duals were frequently infected with HTLV-1.
Characterization of FoxP3+CD4+ T-cell subset in AC
We further focused on the FoxP3+CD4+ T-cell subset as
defined previously (Figure 4A) [27]. First, we investi-
gated the frequency of FoxP3+CD4+ T-cell subset in HD
or AC. The results showed that the frequencies of rTreg
or aTreg in AC
low or AChigh were not significantly differ-
ent from that in HD (Figure 4B and 4 C), but FoxP3low
non-Treg cells were significantly more frequent in the
AChigh population (p= 0.0080, Figure 4D). We next ana-
lyzed the presence of HTLV-1 in each CD4+ T-cell sub-
set by using AC sample. We observed that Tax positivity
in FoxP3− effector/memory CD4+ T cells was higher
than that of FoxP3− naïve CD4+ T cells (p< 0.0001,
Figure 4E). Since effector/memory CD4 T cells are the
most dominant in total CD4 T cells in terms of absolute
cell number, the Tax-expressing cells are most abundant
in effector/memory CD4 T cells (Additional file 3: Figure
S3). More interestingly, Tax positivity in aTreg cells or
FoxP3low non-Treg cells was much higher than that of
rTreg cells in ACboth AC
low and AChigh subjects
(p< 0.0001 or 0.0001, respectively, Figure 4E). These
results indicated that HTLV-1 is frequently present in
aTreg cells or FoxP3
low non-Treg cells.
Characteristics of T-cell subsets in HAM/TSP patients
To investigate the inflammatory aspects of HTLV-1 infec-
tion, we next focused on PBMCs of HAM/TSP patients.
There were no significant differences in the percentage of
CD4+ or CD8+ T cells between HD and HAM/TSP groups
(p=0.3073 and 0.1509, respectively, Figure 5A). The result
of Tax staining showed that HTLV-1 infection was predom-
inantly detected in CD4+ T cells, and at a higher frequency
in CD4+FoxP3+ T cells than CD4+FoxP3− T cells
(p=0.0069, Figure 5B). To characterize the phenotype of
FoxP3+ cells in HAM/TSP patients, we investigated the ex-
pression levels of Treg associated molecules, and found that
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Figure 3 Frequency of HTLV-1-infection in each CD4+ T-cell subset of asymptomatic HTLV-1 carriers. PBMCs from HTLV-1 asymptomatic
carriers (n = 23) were cultivated for 18 hours, stained with anti-CD4, anti-CD8, anti-FoxP3, and anti-Tax antibodies, and analyzed by flow cytometry.
(A) Representative dot plots of CD4 and CD8 and histograms of Tax in CD4+ or CD8+ T cells (Left panel). Right, cumulative results from 23 AC
individuals are shown in graph (Right panel). (B) Representative histograms of Tax expression in FoxP3+ or FoxP3− cell (Left panel). Right,
cumulative results from 23 AC individuals are shown in graph (Right panel). (C) Tax positivity in CD4+ T cells showed significant correlation with
FoxP3 positivity in CD4+ T cells by Spearman’s rank correlation (P= 0.0257, r = 0.48).
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was significantly lower than that in HD (p=0.0328 or
0.00002, respectively, Figure 5C). On the contrary, CD25
expression was high in HAM/TSP patients (p=0.0099,
Figure 5C). We further evaluated FoxP3+CD4+ T-cell sub-
set in HAM/TSP patients. The frequencies of rTreg were
not significantly different from that in HD (p =0.9096,
Figure 5D), but aTreg cells or FoxP3
low non-Treg cells were
remarkably increased (p=0.0250 or 0.0004, Figure 5E and
5F). Furthermore, aTreg cells or FoxP3
low non-Treg cells
showed a high frequency of Tax+cells compared with rTreg
cells (p=0.0069 or 0.0069, respectively, Figure 5G) as
observed in ACs (Figure 4E). These data indicated that
HTLV-1 infection significantly influenced not only the
frequency but also the phenotype of CD4+FoxP3+ T cells
in an inflammatory disease HAM/TSP.
Phenotypical analyses of ATL cells
Previous studies reported that some ATL cells express
FoxP3 or CD25 [30,31,33], but the precise information
about FoxP3+CD4+ T-cell subset of ATL cells remains
unknown. We, therefore, analyzed CD4+ T-cell subsets
for ATL cases. FoxP3 positivity was 80% in ATL cases;
yet the expression level was different among the cases
(Figure 6A), which is consistent with previous reports
[30,31]. In line with the finding in asymptomatic HTLV-
1-infected carriers that the percentage of HTLV-1 in
FoxP3low non-Treg cells or aTreg cells was high (Figure 4E),
ATL cells analyzed in this study did not express
CD45RA, suggesting that FoxP3-expressing ATL cells
might be derived from FoxP3low non-Treg or aTreg cells.
CD25 expression on ATL cells was generally high, but
there was also much variation among the cases
(Figure 6B).
Discussion
FoxP3+ Treg cells play a crucial role in persistent infec-
tion and pathogenesis of chronic viral infection. Previous
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Figure 4 Characterization of FoxP3+CD4+ T-cell subset in AC samples. (A) A result of flow cytometric dot plots of CD45RA and FoxP3 in
CD4+ T cells of an AC sample is shown as an example. FoxP3+CD4+ T cells were classified into three subsets. a, CD45RA+FoxP3low resting Treg
cells (rTreg cells); b, CD45RA
−FoxP3low non-regulatory T cells (FoxP3low non-Treg cells), c, CD45RA
−FoxP3high activated Treg cells (aTreg cells). (B–D)
Frequencies of the FoxP3+CD4+ T-cell subset in HD, AClow, and AChigh. Percentages of resting Treg cells (B), activated Treg cells (C), and FoxP3
low
non-Treg cells (D) in CD4
+ T cells are shown. (E) Representative flow cytometric dot plots of CD45RA and FoxP3 and histograms of Tax expression
in each CD4+ T-cell subset in an AC sample (Left panel). Cumulative results from 13 AClow and 10 AChigh individuals are shown in the graph
(Middle and right panels).
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specific CD8+ T-cell effector functions in chronic human
viral infections such as human immunodeficiency virus,
hepatitis C virus and cytomegalovirus [34,35]. Regarding
this point, FoxP3+ Treg cells play a role in facilitating
viral persistence. In HTLV-1 infection, the frequency of
FoxP3+ cells is indeed correlated with the impairment of
CTL activity against the viral antigen Tax in HAM/TSP
patient [36]. On the other hand, FoxP3+ Treg cells could
prevent tissue damage caused by excessive immune re-
sponse triggered by viral infection. In addition to these
general roles of FoxP3+ Treg cells in chronic viral infec-
tion, FoxP3+ Treg cells should have some specific role in
HTLV-1 infection, because FoxP3+ Treg cells are com-
prised in CD4+ T cells, which are a main host cell popu-
lation of HTLV-1. Here we performed a comprehensive
analysis of CD4+ T-cell subsets in individuals naturally
infected with HTLV-1 and revealed that the frequency of
HTLV-1 infection is positively correlated with the fre-
quency of FoxP3+ T cells (Figure 1E). The increased
FoxP3+ T cells themselves are frequently infected with
HTLV-1 (Figure 3B), suggesting that HTLV-1 utilizes the
FoxP3+ T cells as a host cell. What is the advantage for
HTLV-1 to exist in FoxP3+ T cells? There are two
possibilities for this preference. First, FoxP3+ T cells are
known as hyper-proliferating cells in vivo with a doub-
ling time of 8 days [37], which could contribute to clonal
expansion of infected cells. Second, HTLV-1 can evade
the host immune system by directly infecting this poten-
tially immuno-suppressive cell population. Thus, HTLV-
1-infection of FoxP3+ T cells should enable the virus to
increase or maintain proviral load and achieve persistent
infection.
How then does HTLV-1 infection target FoxP3+ T cells?
This could be explained by the following two mechanisms.
First, FoxP3+ T cells are known to contact with dendritic
cells (DCs) frequently [38], which could increase
the chance of de novo viral infection between DCs and
FoxP3+ T cells. A recent study demonstrated that cell-free
HTLV-1 efficiently infects DCs, and the infected DCs pro-
mote de novo infection of CD4+ T cells [39]. This notion
is consistent with the finding that effector/memory-type
CD45RA− Treg cells, including FoxP3
low non-Treg cells
and FoxP3high aTreg cells, are more frequently infected
with HTLV-1 than CD45RA+ rTreg cells (Figure 4E). Sec-
ond, once FoxP3− T cells are infected with HTLV-1, HBZ
should be expressed in the host cells. Since HBZ is recently
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Figure 5 Detailed characterizations of CD4+ T-cell subsets in HAM/TSP patients. Freshly isolated PBMCs from HAM/TSP patients (n = 10)
were stained with anti-CD4, anti-CD45RA, anti-FoxP3 antibodies and analyzed by flow cytometry. To detect Tax expression, PBMCs were cultivated
for 18 hours before antibody staining. (A) Percentages of CD4+ or CD8+ T cells in HAM/TSP patients. (B) Tax positivity of CD4+, CD8+, non-T,
FoxP3−, or FoxP3+ cell populations in HAM/TSP patients. (C) Expression levels of Treg associated molecules in FoxP3
+ cells of HD or HAM/TSP
patients. (D–F) Frequencies of the FoxP3+CD4+ T-cell subset in HD and HAM/TSP patients. Percentages of rTreg cells (D), aTreg cells (E), and
FoxP3low non-Treg cells (F) in CD4
+ T cells are shown. (G) Tax positivity of each CD4+ T-cell subset in HAM/TSP patients.
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reported to induce FoxP3 expression via enhancing TGF-β
signaling pathway [17,40], HTLV-1 infection is likely to
convert FoxP3− cells into FoxP3+ cells. In addition,
HTLV-1 has a cell-extrinsic effect on FoxP3+ cell gener-
ation. HTLV-1 infected cells secrete CCL22 via expres-
sion of Tax, which indirectly contributes to the
generation and maintenance of HTLV-1 uninfected
FoxP3+ cells [41,42]. This would contribute to an
increased number of HTLV-1-uninfected FoxP3+ cells.
Since FoxP3+ Treg cells play a crucial role in suppres-
sing immune response, the increase of FoxP3+ cells
observed in HTLV-1 infection may contribute to im-
munodeficiency, which is frequently observed in HTLV-
1 infection [43]. On the other hand, the high frequency
of FoxP3+ T cells observed in HAM/TSP patients is
paradoxical, because the pathogenesis of HAM/TSP is
believed to be inflammatory. Therefore, we analyzed the
phenotype of the increased FoxP3+ cells and observed
that CTLA-4 and GITR expression of FoxP3+ T cells in
HAM/TSP patient was significantly reduced compared
to uninfected individuals (Figure 5C). A similar observa-
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Figure 6 Characterization of CD4+ T-cell subsets in ATL cells. PBMCs from ATL patients (n = 10) were stained with anti-CD4, anti-CD45RA,
anti-CD25, and anti-FoxP3 antibodies and analyzed by flow cytometry. (A) The expression pattern of CD45RA and FoxP3 of CD4+ T cells in ATL
patients. (B) The expression pattern of CD25 and FoxP3 of CD4+ T cells in ATL patients.
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FoxP3, GITR, or CTLA-4 mRNA in CD4+CD25+ T cells
of HAM/TSP patients is lower than that of HD [44].
That report used CD4+CD25+ as a marker of Treg cells,
but CD4+CD25+ T cells contain not only FoxP3+ Treg
cells but also FoxP3− activated T cells. Particularly the
proportion of CD4+CD25+FoxP3−activated T cells is up-
regulated in HAM/TSP patients, which is likely to re-
duce the proportion of FoxP3+ Treg cells in CD4
+CD25+
T cells of HAM/TSP patients. Thus, the expression level
of GITR or CTLA-4 in FoxP3+ T cells of HAM/TSP
patients has not been elucidated yet. To avoid this con-
cern, we utilized the multicolor flow cytometry, which
enabled us to show that CTLA-4 and GITR were clearly
down regulated in FoxP3+ T cells of HAM/TSP patients.
Then what is the underlying mechanism of this
phenomenon? We reported recently that HBZ-Tg mice
showed a pro-inflammatory phenotype in spite of the in-
crease of Foxp3+ T cells [17], which is similar to HAM/
TSP patients (Figure 1D). Treg associated molecules were
also down regulated in Foxp3+ T cells of HBZ-Tg mice.
Thus, HBZ-mediated FoxP3 dysfunction may play a role
in the abnormality regarding FoxP3+ cells in HAM/TSP
patients. It has been reported that Tax also contributes
to the dysregulation of FoxP3+ Treg cells. Tax suppresses
FoxP3 expression at transcriptional level [45], which alter-
natively or additionally could contribute to the abnormal
phenotype of FoxP3+ cells. These findings collectively indi-
cate that the increased FoxP3+ Treg cells were functionally
impaired in HAM/TSP patients. Furthermore, FoxP3+
CD4+ T cells in HAM/TSP patient contain an increased
FoxP3+ non-Treg population (Figure 5F), which would con-
tribute to the inflammatory phenotype of HAM/TSP via
generation of pro-inflammatory cytokine-producing CD4+
T cells such as THAM cells [46] or exFoxp3 cells [47].
In the current study, we did not observed FoxP3 re-
pression during Tax expression by ex vivo cultivation.
This result seems to be inconsistent with a previous re-
port that Tax represses FoxP3 expression [45]. There are
two possible explanation of this inconsistency. First,
there is the difference of the ways to express Tax. In the
previous study, the authors used transfection of plasmid
that induces Tax expression by the CMV promoter. We
used endogenous HTLV-1 provirus to express Tax.
Therefore, the expression level of Tax in our current
study should be much lower than that of the previous
study. In addition, Tax expression was induced in a pro-
portion of FoxP3+ cell in our current study. Second,
there are differences in incubation time for Tax expres-
sion. In the previous study, the authors evaluated FoxP3
expression after 48 hours of transfection, whereas we
evaluated FoxP3 expression within 24 hours after Tax
expression.
High expression levels of CD25 are also well documented
in HTLV-1 infection [33]. Consistent with previous
findings, CD25 expression is upregulated in FoxP3+ cells of
HAM/TSP patient (Figure 5C). One determinant of the
susceptibility to HAM/TSP is host genetic polymorphism
such as MHC class 1, which influences the efficiency of
CTL against HTLV-1 [48,49]. HTLV-1-infected individuals
who have HLA class I susceptible for HAM/TSP may allow
high expression of Tax and/or HBZ, which could cause up-
regulation of CD25 molecules in the FoxP3+ cell population
(Figure 5C).
It is controversial whether ATL is a leukemia of FoxP3+
Treg cells or not. However, there is no a priori reason to as-
sume that ATL cells must be exclusively derived from
FoxP3+ Treg cells or non-Treg cells. Indeed, there are previ-
ous reports to support both possibilities. Some studies have
reported that ATL cells have regulatory functions [50,51],
whereas other studies reported no regulatory function in
ATL [52,53]. We showed here that HTLV-1 is frequently
detectable in CD4+FoxP3+ T cells (Figure 3B) in AC. More
than half of ATL cells express FoxP3 (Figure 6), even
though FoxP3 expression in ATL cells is variable as shown
in the present and previous studies [30,31]. These findings
prompt us to propose an idea that more than a half of ATL
cells are possibly derived from FoxP3+ Treg cells. We
reported previously that HBZ expression is constitutively
active but Tax expression is frequently silenced in ATL
cells, which possibly contributes to high frequency of
FoxP3+ ATL.
Conclusion
This study demonstrated that HTLV-1 infection induced
the abnormality of frequency and phenotype of FoxP3+
T cells, suggesting that HTLV-1 has evolved a sophisti-
cated strategy to achieve persistent infection by directly
affecting the central regulator of the host immune sys-
tem. HTLV-1-mediated dysregulation of FoxP3+ T cells
is likely to be a critical cellular mechanism for the
understanding HTLV-1 pathogenicity.
Methods
Clinical samples and ethics statement
PBMCs were obtained from asymptomatic HTLV-1
infected carriers (n = 23), HAM/TSP patients (n = 10),
ATL patients (n = 10), and age-matched healthy controls
(n = 10). Characteristics of each group are presented in
Table 1. ATL patients consist of 2 acute, 4 smoldering
and 4 chronic types of ATL cases. Genomic DNA
extracted from PBMCs was used to determine proviral
load (PVL) as described previously [29]. Briefly, PVL was
quantified by real time PCR and calculated by using gen-
omic DNA of TL-Om1, an ATL cell line with one copy
of complete HTLV-1 provirus, as a standard of 100%.
We defined AC with less than 2% of proviral load as
AClow and AC with more than 2% of proviral load as
AChigh. This study was conducted according to the
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principles expressed in the Declaration of Helsinki and
approved by the Institutional Review Board of Kyoto
University (844 and E-921). All patients provided written
informed consent for the collection of samples and sub-
sequent analysis.
Antibodies
The following antibodies were purchased from BD Phar-
Mingen; purified monoclonal antibody (mAb) for human
CD3 (UCHT1), CD4 (RPA-T4), CD8a (RPA-T8),
CD45RA (NI100) and CTLA-4 (BNI3). Purified mAbs
for human CD25 (BC96), GITR (eBio AITR) and FoxP3
(236A/E7) were purchased from eBioscience.
Flow cytometric analysis
PBMCs were isolated with Ficoll-Isopaque (GE Healthcare)
gradient centrifugation. Flow cytometric analyses were car-
ried out using a FACS CantoII with Diva Software (BD
Pharmingen), and the data were analyzed by FlowJo soft-
ware (Treestar). To discriminate dead cells, we used LIVE/
DEAD Fixable Near-IR Dead Cell Stain Kit (Invitrogen).
For cell surface staining, 106 cells were incubated with
mAbs for 30 minutes at 4°C, and then analyzed. For intra-
cellular staining, we used a human FoxP3 staining kit
according to the manufacture’s protocol (eBioscience). To
distinguish FoxP3+ and FoxP3− cell population clearly, we
used isotype control according to the manufacture’s
recommendation. To detect the viral antigen Tax, we cul-
tured PBMCs from ACs or HAM/TSP patients for 12–18
hours and stained with monoclonal antibodies against
FoxP3 or Tax (MI-73) [54], and then analyzed by flow
cytometry.
Statistical analysis
To compare 2 groups when data were determined to
have a Gaussian distribution, the Student t test was used.
If data did not have a Gaussian distribution, the Mann–
Whitney U test was used for unpaired data, and the Wil-
cox signed-ranks test was used for paired data. The AC
group and HD did not differ significantly in sex or age,
using chi-squared test and Mann–Whitney U test. Dif-
ferences with P< 0.05 were considered to be statistically
significant. Correlations were evaluated using Spear-
man’s rank correlation.
Additional files
Additional file 1: Figure S1. Absolute cell numbers of each CD4+T-cell
subset in HTLV-1 infected individuals. (A) Absolute cell numbers of CD4+
T cells in 4 distinct subjects. Data shown are gated on lymphocyte
fraction based on the dot plot pattern of SSC and FSC. (B and C)
Absolute cell numbers of FoxP3−CD45RA+ naïve CD4+ T cells (B) or FoxP3
−CD45RA− effector/memory CD4+ T cells (C). (D) Absolute cell numbers
of FoxP3+ cells in CD4+ T cells.
Additional file 2: Figure S2. Effect of ex vivo cultivation on FoxP3 and
CD45RA expression. The percentages of FoxP3 and CD45RA expression in
CD4+ T cells both before and after ex vivo culture are shown from 5
distinct ACs.
Additional file 3: Figure S3. Frequency of each CD4 T-cell subset in
Tax-expressing cell population in AC. Cumulative results from 23AC
individuals are shown in the graph.
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